ABL Bio Inc. (KOSDAQ:298380)
South Korea · Delayed Price · Currency is KRW 45,600
-2,400 (-5.00%)
Oct 12, 2026, 3:30 PM KST
ABL Bio Market Cap
ABL Bio has a market cap or net worth of 2.55 trillion as of October 12, 2026. It is the 6,761st most valuable company in the world and the 163rd biggest in South Korea. Its market cap has decreased by 50.68% in one year.
Market Cap
2.55T
Enterprise Value
2.44T
Revenue
34.28B
Global Rank
Country Rank
#163 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since December 19, 2018, ABL Bio's market cap has increased from 608.61B to 2.55T, an increase of 319.48%. That is a compound annual growth rate of 20.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 2.55T | -76.84% |
| Dec 30, 2025 | 11.03T | 663.70% |
| Dec 30, 2024 | 1.44T | 22.53% |
| Dec 28, 2023 | 1.18T | 7.19% |
| Dec 29, 2022 | 1.10T | 5.54% |
| Dec 30, 2021 | 1.04T | -27.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Epis Holdings | 8.46T |
| HLB Co., Ltd. | 6.07T |
| SK Biopharmaceuticals | 5.69T |
| SK bioscience | 2.87T |
| LigaChem Biosciences | 2.70T |
| OliX Pharmaceuticals | 2.67T |
| Voronoi | 2.51T |
| Peptron | 2.13T |